AVAH · Aveanna Healthcare Holdings, Inc.
$13.82
+0.20 (+1.47%)
At close · Aug 27
Market Cap
$2.97B
Shares
218.22M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$13.82
Open$13.62
Day$13.52–14.00
52W close$6.22–13.82
Avg vol 30d3.0M
Short int5.3M · 2.4% float · 1.6d
Short vol36%
Last earningsAug 13, 2026
DataApr 2021–Aug 2026
Filing10-Q · Aug 13
Up next
Next earnings call
Dec 3, 2026
Est · unconfirmed
· in 14 wks
FQ3-27 quarter ends
~Oct 1, 2026
Est
filed Aug 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.5 · calm
Equity put/call 0.39
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+67%
above
Price vs 50-day avg
+38%
above
RSI (14)
80
overbought
MACD trend
Positive
52-week position
100%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+43%
trailing
6-month return
+91%
trailing
YTD return
+69%
this year
Relative strength
+76%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +54 funds added
Insider flow
Distributing
Net -$773.1M over 90 days · 100% sells
Short interest
Rising
2.45% of float · ▲ +21.0% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
212 holders — near 3-yr high, broad support
Squeeze score
63
elevated · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
33%
expanding
EPS growth
+1850%
Y/Y
Free cash flow
$109.9M
Valuation
P/E 10.8
below peers
Balance sheet
$1.1B
net debt
Quant / Vol
risk profile
Volatility
50%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 13, 2026
full year 2026
Adjusted EBITDA
Initiated
at least $365M
long-term
Long-term private duty services organic growth rate
5% – 6%
Long-term home health and hospice organic growth rate
8% – 10%
full-year 2026
Adjusted EBITDA
Non-GAAP
$365M
2026
PDS volume from preferred payer mix
up to 70%
going forward
PDS growth
5% – 6%
Prior guidance
period ended
· from the 8-K filed Jan 14, 2026
Revenue
· full fiscal year 2025 (year ending January 3, 2026)
$2.43B – $2.45B
Adjusted EBITDA
· full fiscal year 2025 (year ending January 3, 2026)
$318M – $322M
Normalized Adjusted EBITDA
· full fiscal year 2025 (year ending January 3, 2026)
$298M – $302M
Guided vs delivered
· last 3 settled
Revenue
Full Year 2025
guided at least $2.38B
$2.43B
In line
Full year 2024 revenue
full year 2024
guided $2B
$2.02B
Beat +1.2%
Full-year revenue
full year 2023
guided $1.87B – $1.88B
$1.9B
Beat +1.1%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+67%
Bullish
Price vs 50-day avg
+38%
Bullish
RSI (14)
80
Bearish
MACD trend
Positive
Bullish
52-week position
100%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $10 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +54 funds added
Insider flow
Distributing
Net -$773.1M over 90 days · 100% sells
Short interest
Rising
2.45% of float · ▲ +21.0% MoM · 1.6 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
212 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $6
Now $14 · 100%
Range high $14
vs 200-day avg +67%
vs 50-day avg +38%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cost of revenue rate | $31.9 | six months ended July 4, 2026 | — |
| Field contribution non-GAAP | $231.08M | six months ended July 4, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Gross margin 423.95M
-192.87M Branch and regional administrative expenses
= Field contribution 231.08M
|
|||
| Revenue rate | $44.53 | six months ended July 4, 2026 | — |
| Spread rate | $12.63 | six months ended July 4, 2026 | — |
| Unique patients served ("UPS") | 95K | Q2 FY2026 | — |
|
|
|||
| PDS Hours | 12.06M | three-month period ended April 4, 2026 | — |
| Adjusted EBITDA non-GAAP | $320.86M | fiscal year ended January 3, 2026 | — |
|
|
|||
| Adjusted net income non-GAAP | $129.8M | fiscal year ended January 3, 2026 | — |
| Adjusted net income per diluted share non-GAAP | $0.6 | fiscal year ended January 3, 2026 | +0.0% |
|
|
|||
| EBITDA | $254.74M | fiscal year ended January 3, 2026 | — |
| Field contribution margin | 17.5% | Q4 fiscal year ended January 3, 2026 | — |
| Free cash flow non-GAAP | $130.97M | fiscal year ended January 3, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net cash provided by operations 125.86M
-7.45M Purchases of property and equipment, and software
+1.32B Proceeds from issuance of term loans, net of debt issuance costs
-1.31B Principal payments of term loans
-8.89M Principal payments of notes payable and financing lease obligations
+12.56M Settlements with swap counterparties
= Free cash flow 130.97M
|
|||
| Home health episodic admissions | 30.4K | fiscal year ended January 3, 2026 | — |
|
|
|||
| Home health episodic mix | 76.8% | fiscal year ended January 3, 2026 | — |
|
|
|||
| Home health revenue per completed episode | $3,206 | fiscal year ended January 3, 2026 | — |
|
|
|||
| Home health total admissions | 39.6K | fiscal year ended January 3, 2026 | — |
|
|
|||
| Home health total episodes | 51.4K | fiscal year ended January 3, 2026 | — |
|
|
|||
| Hours | 46.12M | fiscal year ended January 3, 2026 | — |
| MS Revenue rate | $570.53 | Q4 fiscal year ended January 3, 2026 | — |
| MS Spread rate | $285.28 | Q4 fiscal year ended January 3, 2026 | — |
| PDS Revenue rate | $43.74 | Q4 fiscal year ended January 3, 2026 | — |
| PDS Spread rate | $12.12 | Q4 fiscal year ended January 3, 2026 | — |
| Unique patients served | 363K | fiscal year ended January 3, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AVAH
this stock
Aveanna Healthcare Holdings, Inc.
|
$2.97B | +69.2% | +20.2% | 10.8 | 2.4% |
|
HCA
HCA Healthcare, Inc.
|
$93.03B | -10.2% | +7.1% | 14.5 | 2.8% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$30.21B | -6.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$22.08B | +34.7% | +0.9% | 10.6 | 3.1% |
|
FMS
Fresenius Medical Care AG
|
$12.38B | -2.3% | +5.9% | — | 0.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AVAH | +6.6% | +42.6% | +91.2% | +47.2% | +69.2% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | +5.4% | +38.7% | +76.5% | +44.0% | +56.1% |
Key facts
CIK
1832332
CUSIP
05356F105
13F (30d)
191 filings
191 filers
Visit website
Investor relations